Loading quote...
Inovio Pharmaceuticals, Inc. (INO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Global Select. The most recent ex-dividend date was September 28, 2017, with payment scheduled for October 16, 2017. market capitalization is approximately $61M.